Borussia Dortmund's new signing Sebastien Haller will be out for several months as the striker has to undergo chemotherapy for a malignant testicular tumour, the Bundesliga club said on Saturday.
Two major studies show that many people with breast and lung cancers may forgo chemotherapy and still live longer, signaling a waning need for what was long seen as the standard of cancer care.
It may be possible to "soften-up" cancers before hitting them with chemotherapy drugs, researchers suggest.
Borussia Dortmund's new signing Sebastien Haller will be out for several months as the striker has to undergo chemotherapy for a malignant testicular tumour, the Bundesliga club said on Saturday.
Two major studies show that many people with breast and lung cancers may forgo chemotherapy and still live longer, signaling a waning need for what was long seen as the standard of cancer care.
It may be possible to "soften-up" cancers before hitting them with chemotherapy drugs, researchers suggest.